Average stock performance after each discretionary buy, measured at 1, 3 and 6 months. 7 buys in history.
Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Charah Solutions, Inc. | 263,342 | reported | 14 Jun 2023 | tx 7+36,126 |
| Evoke Pharma Inc | 125,000 | reported | 06 Nov 2025 | tx 2−9,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Nov 2025 | SALE | Evoke Pharma Inc | 5,000 | 10.66 USD | |
| 06 Nov 2025 | SALE | Evoke Pharma Inc | 4,000 | 10.65 USD | |
| 02 Jun 2023 | PURCHASE | Charah Solutions, Inc. | 600 | 5.84 USD | |
| 13 Jun 2023 | PURCHASE | Charah Solutions, Inc. | 3,000 | 5.90 USD | |
| 14 Jun 2023 | PURCHASE | Charah Solutions, Inc. | 4,100 | 5.87 USD | |
| 12 Jun 2023 | PURCHASE | Charah Solutions, Inc. | 1,762 | 5.88 USD | |
| 13 Jun 2023 | PURCHASE | Charah Solutions, Inc. | 13,335 | 5.89 USD | |
| 08 Jun 2023 | PURCHASE | Charah Solutions, Inc. | 8,000 | 5.82 USD | |
| 07 Jun 2023 | PURCHASE | Charah Solutions, Inc. | 5,329 | 5.78 USD |